Effects of olopatadine hydrochloride nasal spray 0.6% in the treatment of seasonal allergie rhinitis: A phase III, multicenter, randomized, double-blind, active- and placebo-controlled study in adolescents and adults

Clinical Therapeutics

Volumn 31, Issue 1, 2009, Pages 99-107

  Shah, Shailen R ^a   Nayak, Anjuli ^b   Ratner, Paul ^c   Roland, Peter ^d   Michael Wall, G ^e  

^a Allergy and Asthma Consultants NJ/PA   (United States)

^b Sneeze Wheeze and Itch Associates LLC ^*  (United States)

^c Sylvana Research   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e ALCON RESEARCH LTD   (United States)

Author keywords

allergic rhinitis; azelastine; nasal spray; olopatadine

Indexed keywords

ALLERGEN; AZELASTINE; NOSE SPRAY; OLOPATADINE; PATANESE; PLACEBO; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; BITTER TASTE; BOY; CARDIOVASCULAR PARAMETERS; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ELECTRONICS; EPISTAXIS; EVENING DOSAGE; FATIGUE; FEMALE; HAY FEVER; HEADACHE; HISTORY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; MULTICENTER STUDY; NOSE; NOSE DISEASE; NOSE INFECTION; NOSE ULCER; PHASE 3 CLINICAL TRIAL; PHYSICAL PARAMETERS; POPULATION; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; RHINITIS; SCORING SYSTEM; SIDE EFFECT; SNEEZING; SYMPTOM; THROAT IRRITATION; UNITED STATES; XEROSTOMIA;

ADMINISTRATION, INTRANASAL; ADOLESCENT; ADULT; AGED; ANTI-ALLERGIC AGENTS; CHILD; DIBENZOXEPINS; DOUBLE-BLIND METHOD; EPISTAXIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PHTHALAZINES; RHINITIS, ALLERGIC, SEASONAL; TASTE; UNITED STATES; YOUNG ADULT;

EID: 60649089429     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2009.01.016     Document Type: Article

References (27)

1. Yanni J.M., Stephens D.J., Miller S.T., et al. The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic/ antihistamine agent. J Ocul Pharmacol Ther 12 (1996) 389-400
2. Leonardi A., and Abelson M.B. Double-masked, randomized, placebo-controlled clinical study of the mast cell-stabilizing effects of treatment with olopatadine in the conjunctival allergen challenge model in humans. Clin Ther 25 (2003) 2539-2552
3. Sharif N.A., Xu S.X., Miller S.T., et al. Characterization of the ocular antiallergic and antihistamine effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases. J Pharmacol Exp Ther 278 (1996) 1252-1261
4. Ohmori K., Hasegawa K., Tamura T., et al. Properties of olopatadine hydrochloride, a new antiallergic/ antihistamine drug. Arzneimittelforschung 54 (2004) 809-829
5. Ohmori K., Hayashi K., Kaise T., et al. Pharmacological, pharmacokinetic and clinical properties of olopatadine hydrochloride, a new antiallergic drug. Jpn J Pharmacol 88 (2002) 379-397
6. Ratner P.H., Hampel F.C., Amar N.J., et al. Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis to mountain cedar. Ann Allergy Asthma Immunol 95 (2005) 474-479
7. Meltzer E.O., Hampel F.C., Ratner P.H., et al. Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol 95 (2005) 600-606
8. Bousquet J., Van Cauwenberge P.B., Khaltaev N., and Ana Workshop Group and the World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 108 Suppl 5 (2001) S147-S334
9. Wallace D.V., Dykewicz M.S., Bernstein D.I., et al. The diagnosis and management of rhinitis: An updated practice parameter. J Allergy Clin Immunol 122 (2008) S1-S84
10. Settipane R.A. Demographics and epidemiology of allergic and nonallelic rhinitis. Allergy Asthma Proc 22 (2001) 185-189
11. Skoner D.P. Allergic rhinitis: Definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol 108 Suppl 1 (2001) S2-S8
12. Salzano F.A., d'Angelo L., Motta S., et al. Allergic rhinoconjunctivitis: Diagnostic and clinical assessment. Rhmology 30 (1992) 265-275
13. Hollingsworth H.M. Allergicrhinocon-junctivitis: Current therapy. Hosp Pract (Minneap) 31 (1996) 61-73
14. Greiner A.N. Allergic rhinitis: Impact of the disease and considerations for management. Med Clin North Am 90 (2006) 17-38
15. Prenner B.M., and Schenkel E. Allergic rhinitis: Treatment based on patient profiles. Am J Med 119 (2006) 230-237
16. Juniper E.F., Ståhl E., Doty R.L., et al. Clinical outcomes and adverse effect monitoring in allergic rhinitis. J Allergy Clin Immunol 115 Suppl 1 (2005) S390-S413
17. Galant S.P., and Wilkinson R. Clinical prescribing of allergic rhinitis medication in the preschool and young school-age child: What are the options?. BioDrugs 15 (2001) 453-463
18. Astehn (azelastine hydrochloride) [package insert] (April 2007), Meda Pharmaceuticals Inc, Somerset, NJ. http://www.astehn.com/pdf/astehn_pi.pdf Accessed December 19, 2008
19. Juniper E.F., and Guyatt G.H. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 21 (1991) 77-83
20. Juniper E.F., Guyatt G.H., and Jaeschke R. How to develop and validate a new health related quality of life instrument. In: Spilker B. (Ed). Quality of Life and Pharmacoeconomics in Clinical Trials. 2nd ed. (1996), Lippmcott-Raven, Philadelphia, Pa 49-56
21. Lieberman P., Kaliner M.A., and Wheeler W.J. Open-label evaluation ofazelastine nasal spray in patients with seasonal allergic rhinitis and nonallelic vasomotor rhinitis. Curr Med Res Opin 21 (2005) 611-618
22. Weiler J.M., Meltzer E.O., Benson P.M., et al. A dose-ranging study of the efficacy and safety of azelastine nasal spray in the treatment of seasonal allergic rhinitis with an acute model. J Allergy Clin Immunol 94 (1994) 972-980
23. Lee C., and Corren J. Review of azelastine nasal spray in the treatment of allergic and non-allergic rhinitis. Expert Opin Pharmacother 8 (2007) 701-709
24. Berger W.E., White M.V., and Rhinitis Study Group. Efficacy of azelastine nasal spray in patients with an unsatisfactory response to lorata-dine. Ann Allergy Asthma Immunol 91 (2003) 205-211
25. LaForce C.F., Corren J., Wheeler W.J., Berger W.E., and Rhinitis Study Group. Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine. Ann Allergy Asthma Immunol 93 (2004) 154-159
26. The Medical Letter on Drugs and Therapeutics. Azelastine Nasal Spray for Allergic Rhinitis 39 (1997), The Medical Letter, Inc, New Rochelle, NY 45-47
27. Stokes M., Amorosi S.L., Thompson D., et al. Evaluation of patients' preferences for triamcinolone acetonide aqueous, fluticasone propionate, and mometasone furoate nasal sprays in patients with allergic rhinitis. Otolaryngol Head Neck Surg 131 (2004) 225-231